Engineering PD-L1 Cellular Nanovesicles Encapsulating Epidermal Growth Factor for Deep Second-Degree Scald Treatment.

Xiao-Feng Zhu,Dan-Dan Su,Xin-Hui Tian,Cheng Yang,Wei-Xian Zhang,Xin-Rui Yang,Man-Qi Zhang,Li-Fang Xi,Lan Wei,Hong-Bo Chen,Fang Cheng,Yu-Xin Pang
DOI: https://doi.org/10.1166/jbn.2022.3300
2022-01-01
Journal of Biomedical Nanotechnology
Abstract:Scars are common and intractable consequences after scalded wound healing, while monotherapy of epidermal growth factors does not solve this problem. Maintaining the stability of epidermal growth factors and promoting scarless healing of wounds is paramount. In this study, engineering cellular nanovesicles overexpressing PD-L1 proteins, biomimetic nanocarriers with immunosuppressive efficacy, were successfully prepared to encapsulate epidermal growth factors for maintaining its bioactivity. Remarkably, PD-L1 cellular nanovesicles encapsulating epidermal growth factors (EGF@PDL1 NVs) exerted desired therapeutic effect by attenuating the overactivation of T cell immune response and promoting skin cells migration and proliferation. Hence, EGF@PD-L1 NVs promoted wound healing and prevented scarring in deep second-degree scald treatment, demonstrating a better effect than using individual PD-L1 NVs or EGF. This research proved that EGF@PD-L1 NVs is considered an innovative and thorough therapy of deep second-degree scald.
What problem does this paper attempt to address?